BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 11424125)

  • 1. HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease.
    Sagnelli E; Coppola N; Scolastico C; Mogavero AR; Filippini P; Piccinino F
    J Med Virol; 2001 Jul; 64(3):350-5. PubMed ID: 11424125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus.
    Jilg W; Sieger E; Zachoval R; Schätzl H
    J Hepatol; 1995 Jul; 23(1):14-20. PubMed ID: 8530804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus.
    Drosten C; Nippraschk T; Manegold C; Meisel H; Brixner V; Roth WK; Apedjinou A; Günther S
    J Clin Virol; 2004 Jan; 29(1):59-68. PubMed ID: 14675872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatita B and C virus infections in patients with hepatocellular carcinoma].
    Crespo J; Dueñas C; Sánchez-Antolín G; Fábrega E; Carte B; Pons-Romero F
    Med Clin (Barc); 1996 Feb; 106(7):241-5. PubMed ID: 8667672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance.
    Fukuda R; Ishimura N; Niigaki M; Hamamoto S; Satoh S; Tanaka S; Kushiyama Y; Uchida Y; Ihihara S; Akagi S; Watanabe M; Kinoshita Y
    J Med Virol; 1999 Jul; 58(3):201-7. PubMed ID: 10447413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of previous HBV infection on the course of chronic hepatitis C.
    De Maria N; Colantoni A; Friedlander L; Leandro G; Idilman R; Harig J; Van Thiel DH
    Am J Gastroenterol; 2000 Dec; 95(12):3529-36. PubMed ID: 11151889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
    Sagnelli E; Coppola N; Scolastico C; Filippini P; Santantonio T; Stroffolini T; Piccinino F
    Hepatology; 2000 Nov; 32(5):1106-10. PubMed ID: 11050062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients.
    Jang JY; Jeong SW; Cheon SR; Lee SH; Kim SG; Cheon YK; Kim YS; Cho YD; Kim HS; Jin SY; Kim YS; Kim BS
    Korean J Hepatol; 2011 Sep; 17(3):206-12. PubMed ID: 22102387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
    N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population.
    Fabris P; Baldo V; Baldovin T; Bellotto E; Rassu M; Trivello R; Tramarin A; Tositti G; Floreani A
    J Clin Gastroenterol; 2008; 42(5):527-32. PubMed ID: 18277889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection.
    Uchida T; Kaneita Y; Gotoh K; Kanagawa H; Kouyama H; Kawanishi T; Mima S
    J Med Virol; 1997 Aug; 52(4):399-405. PubMed ID: 9260688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    Arch Virol; 1997; 142(3):535-44. PubMed ID: 9349299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus markers in anti-HBc only positive individuals.
    Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
    J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of hepatitis B core antibody as the only marker of hepatitis B infection].
    Colomina-Rodríguez J; González-García D; Burgos-Teruel A; Fernández-Lorenz N; Guerrero-Espejo A
    Enferm Infecc Microbiol Clin; 2005 Feb; 23(2):80-5. PubMed ID: 15743579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors.
    Pereira JS; Gonçales NS; Silva C; Lazarini MS; Pavan MH; Fais VC; Gonçales Júnior FL
    Braz J Med Biol Res; 2006 Apr; 39(4):525-31. PubMed ID: 16612476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course.
    Sagnelli E; Coppola N; Messina V; Di Caprio D; Marrocco C; Marotta A; Onofrio M; Scolastico C; Filippini P
    Hepatology; 2002 Nov; 36(5):1285-91. PubMed ID: 12395342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients.
    Giannini E; Ceppa P; Botta F; Fasoli A; Romagnoli P; Ansaldi F; Durando P; Risso D; Lantieri PB; Icardi GC; Testa R
    Liver Int; 2003 Feb; 23(1):12-8. PubMed ID: 12640722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.